advertisement

---

Lee J 6

Showing records 1 to 6 | Display all abstracts from Lee J

98956 Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
Park SW
Pharmaceuticals (Basel, Switzerland) 2022; 15:

---

98624 Proteome alterations in the aqueous humor reflect structural and functional phenotypes in patients with advanced normal-tension glaucoma
Lee SH
Scientific reports 2022; 12: 1221

---

98956 Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
Lee J
Pharmaceuticals (Basel, Switzerland) 2022; 15:

---

98624 Proteome alterations in the aqueous humor reflect structural and functional phenotypes in patients with advanced normal-tension glaucoma
Jung JH; Park TK
Scientific reports 2022; 12: 1221

---

98956 Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
Kook MS
Pharmaceuticals (Basel, Switzerland) 2022; 15:

---

98624 Proteome alterations in the aqueous humor reflect structural and functional phenotypes in patients with advanced normal-tension glaucoma
Moon CE; Han K; Lee J; Lee HK; Ji YW; Kim CY
Scientific reports 2022; 12: 1221

---